Background {#Sec1}
==========

A stroke during pregnancy or puerperium is a rare event, but markedly affects the future life of the woman and her family. Pregnancy-associated stroke (PAS) accounts for up to 15% of maternal deaths \[[@CR1]\]. The reported incidence of PAS and the distribution of stroke subtypes, ischaemic stroke (IS), intracerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH) and cerebral venous thrombosis (CVT), varies greatly due to different inclusion criteria and study designs. A recent meta-analysis reported an incidence of 30 strokes per 100,000 deliveries among all pregnancies \[[@CR2]\]. The incidence of PAS varies depending on gestational age, with the greatest risk observed during the third trimester, delivery and the early postpartum period \[[@CR3], [@CR4]\]. The latest studies indicate an increase in the PAS incidence, primarily as a result of an increase in hypertensive disorders of pregnancy and cardiac disease in pregnant women \[[@CR5], [@CR6]\].

Pregnancy and postpartum period increase the stroke risk compared to non-pregnant time. The estimated incidence of stroke during reproductive age is 10--20 per 100,000 person-years \[[@CR7], [@CR8]\] and during pregnant and puerperal time 34 per 100,000 person-years (assuming the duration of pregnancy to be 40 weeks and defining puerperium as 6 weeks postpartum). Underlying diseases such as prothrombotic conditions, heart disease and anomalies of cerebral vasculature are risk factors for stroke also during pregnancy \[[@CR9]--[@CR12]\], while women with PAS are less likely to have conventional risk factors than non-pregnant women who suffer a stroke at the same age \[[@CR13], [@CR14]\]. Pregnancy-related increase in stroke risk is thought to be a result of hemodynamic and coagulation system changes and pregnancy complications such as hypertensive disorders of pregnancy \[[@CR5], [@CR10], [@CR12], [@CR15]--[@CR17]\], infections \[[@CR9], [@CR10], [@CR12]\], haemorrhage \[[@CR10]\] and fluid and electrolyte imbalance \[[@CR10], [@CR12]\].

The outcome of stroke varies, but full recovery is possible, particularly in high-income countries. Since these women are of reproductive age, they often wish to conceive again. However, there is significant uncertainty surrounding the potential risks related to subsequent pregnancies and data on future health and long-term prognosis of these women are limited. The aim of this systematic review is to summarise the current knowledge on the subsequent pregnancies and future health of women with PAS and knowledge gaps in order to highlight the need for further research on the topic, essential for adequate counselling, pregnancy surveillance and secondary prevention throughout life in the future.

Methods {#Sec2}
=======

The literature search was conducted to identify studies reporting subsequent pregnancy outcomes and future cardiovascular health among women with a history of PAS in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines \[[@CR18]\]. Relevant studies were identified covering the period from January 1980 to September 2018. We searched Ovid Medline, PubMed, Cochrane Library and CINAHL with the following terms: "stroke" or "cerebrovascular disorder" or specific stroke types separately and "pregnancy" or \"postpartum period and "follow-up" or "recurrence" (see Additional file [1](#MOESM1){ref-type="media"} for detailed search strategy). Reference lists from relevant articles were assessed in order to identify additional potential articles. Articles were included if they were published in English and included women with a history of pregnancy-associated or puerperal stroke. Of the stroke subtypes, we included IS, CVT, ICH and SAH. TIA was excluded. Articles were included if information on at least one of the following outcomes was provided: 1) recurrence of stroke during subsequent pregnancy, 2) number of subsequent pregnancies and their outcomes, 3) subsequent cardiovascular health. We excluded case reports and studies that limited their follow-up to the mortality and neurological recovery from the initial stroke.

Two authors (LK and PI) screened the titles and abstracts identified through the literature search. If eligibility remained unclear, the full article was reviewed. Disagreements were resolved through consensus. Data on the number of women with PAS, the number of women with PAS who had subsequent pregnancies, the number of pregnancies and their outcomes and complications, data on future health and the duration of the follow-up were extracted from the eligible articles.

Results {#Sec3}
=======

Figure [1](#Fig1){ref-type="fig"} shows the flow diagram of the review process. We screened 615 records, 157 abstracts and 69 full-texts articles. Fifteen articles included women with PAS but did not provide sufficient data to identify the outcomes for the subgroup. All twelve included articles mainly reported outcomes of women with a history of non-pregnancy associated stroke (NPAS); only 3--33% of women included in the cohorts had suffered a PAS. We found no studies focusing solely on women with PAS. Table [1](#Tab1){ref-type="table"} shows the details of the included studies \[[@CR19]--[@CR30]\]. We identified 252 cases with PAS who were included in the follow-up of the outcomes of interest: 135 women for subsequent pregnancies and 123 women for future health. CVT was the index event in 103/135 women (76%) for whom subsequent pregnancies were reported.Fig. 1Flow diagram of the review processTable 1Study detailsAuthorPublication yearCountryData collection yearsStudy cohortMethod of follow-upWomen in cohort (n)PAS women (n)PAS women (%)Type of PASDuration of follow-upSubsequent pregnanciesFuture healthLanzino et al. \[[@CR19]\]1991Italy (single centre)1978--1988prospective cohort of patients aged 16--45 with IS or TIAclinical visit or telephone interview5923IS (pp)mean 5.8 y, range 6mo-11 yxLamy et al. \[[@CR20]\]2000France (9 centres)1987--1997retrospective cohort of women aged 15--40 admitted for first IS or CVTwritten questionnaire, phone interview, patient records verification of substequent strokes41137928 IS/9 CVTmean 5, SD 2.4, range 0.8--11.3 yxMehraein et al. \[[@CR21]\]2003Germany (single centre)1976--1996retrospective cohort of patients treated for CVTtelephone interview, mailed questionnaire394\*10CVT (2 pp., 1 w9, 1 w40)mean 10.25, range 1--20 yxBreteau et al. \[[@CR22]\]2003France (2 centres)1995--1998retrospective cohort of patient with CVT from two hospitals follow up by visit/phonevisit or telephone interview4237CVT (pp)median 36, range 12--60 moxCoppage et al. \[[@CR21]\]2004USA (3 centres)1990--2002reprospective cohort of pregnant women with a history strokehospital charts234171 CVT (pp); 1 NS (w6); 1 NS (w39); 1 IS (pp)nrxFerro et al. \[[@CR23]\]2004multinational, multicentre1998--2001prospective international multicentre study of CVT patientsclinical visits, telephone interview4657717CVT (24 p, 53 pp)mean 18.6, SD 11.1, median 16 moxAppenzeller et al. \[[@CR24]\]2005Brazil (single centre)1992--2002retrospective cohort patients (subgroup of women) with CVTfollow up by neurology/hematolyogy department18633CVT (pp)mean 46, range 11--145 moxxErtresvg et al. \[[@CR30]\]2007Norway (single centre)1997--1999prospective case-control study of women referred to neurology due to transient neurological symptomsmailed questionnaires4125IS (p)5 yxCrovetto et al. \[[@CR25]\]2012Italy (single centre)2000--2009retrospective cohort of w12 beyond pregnant women with a history of IScontact at least at 6 mo, phone contact in case of no show2414IS (p)nrxGastrich et al. \[[@CR26]\]2012New Jersey (non federal hospitals)1994--2009retrospective case-control register study of pre-eclamptic women with or without MI/strokeregister/hospital charts3539025SAH/ICH/IS/CVT\*\*\*up to 16 yearsxCiron et al. \[[@CR27]\]2013France (4 centres)1995--2012retrospective cohort of women with CVT at age 15--40telephone interview, clinical visit offered62610CVT (4 p, 2 pp)mean 89.5+/−60.6 mo, median 76 mo, \~ 6 yxAlebeek et al. \[[@CR28]\]2018Netherlands (single centre)1980--2010prospective cohort of patients aged 18--50 with IS or TIAtelephone interview, mailed questionnaire21320\*\*9ISmean 14.8, SD 10.0 yxx*PAS* Pregnancy-associated stroke, *p* pregnancy, *pp* postpartum, *w* pregnancy week, *IS* ischemic stroke, *ICH* intracerebral hemorrhage, *SAH* subarachnoid hemorrhage, *CVT* cerebral venous thrombosis, *y* year, *mo* month, *nr* not reported. \*It is possible that there were more womenwith PAS in the cohort, but it was stated that 4 PAS women had subsequent pregnancies. \*\* Study included patients with ischemic stroke (*n* = 9) or TIA (*n* = 11) as PAS types, but did not specify outcomes between these subtypes. \*\*\* Numbers not specified

Course of subsequent pregnancies {#Sec4}
--------------------------------

Of the 52 women with a history of PAS, 26 (50%) had subsequent pregnancies; the studies by Ciron et al. \[[@CR27]\] and Ferro et al. \[[@CR23]\] were excluded from this calculation, as they do not report the number of women with subsequent pregnancies. The included studies reported a total of 55 pregnancies. Outcomes were reported in 42 of these pregnancies and they were the following: 32 live births (76%), one foetal death (2%), six miscarriages (14%) and three induced abortions (7%). Pregnancy complications were reported by all but one study \[[@CR20]\]. The studies included 22 pregnancies that proceeded beyond 22 gestational weeks, i.e. excluding miscarriages and induced abortions. Of these 22 pregnancies, 17 (77%) were uncomplicated/uneventful, three (13%) were complicated by premature rupture of membranes (\< 37 gestational weeks), one (5%) with pre-eclampsia and one (5%) with foetal death. All of the complications reported were from the study by Coppage et al. \[[@CR21]\]. The information on subsequent pregnancies and recurrence of stroke during pregnancy is presented in Table [2](#Tab2){ref-type="table"}.Table 2Subsequent pregnancies and their outcomes in women with a history of PASAuthorPAS women (n)CVT (n)IS (n)NS (n)Women with subsequent pregnancies (n)Pregnancies (n)Miscarriage (n)Induced abortion (n)Live births (n)Fetal death (n)Pregnancy \> w22 complications raported (n)Uncomplicated pregnancies (n)PROM (n)Pre-eclampsia (n)Stroke recurrence(n)Underlying diseaseAppenzeller et al. \[[@CR24]\]660022nrnr2022000noneLamy et al. \[[@CR20]\]3792801524nrnr110nrnrnrnrnr2 CVT patients: hematologic diseaseCrovetto et al. \[[@CR25]\]101011001011000Antiphospholipid syndromeCoppage et al. \[[@CR21]\]4112493051613101 patient PSD; 1 patient PCD; 2 patients uncontrolled hyprtensionCiron et al.\* \[[@CR27]\]6600nr21100000011 patient: sickle cell diseaseMehraein et al. \[[@CR29]\]440046105055000nrFerro et al. \*\* \[[@CR23]\]777700nr11128088000nrTotal1351033022655633212217311*CVT* Cerebral vein thrombosis, *IS* Ischemic stroke, *NS* stroke type not specified, *PROM* premature rupture of membranes, *PSD* Protein S deficiency, *PCD* Protein C deficiency, *nr* not reported for women with PAS. \*Ciron et al. reported that in 9.7% (*n* = 6) of 62 women with CVT in reproductive age it was related to pregnancy. The authors report the number of pregnancies and their outcomes for one women with a PAS history, but do not state whether the other women with PAS history had pregnancies. \*\*Ferro et al. reported that there were 8 uncomplicated pregnancies, 1 miscarriage and 2 induced abortions, but do not state amongst how many women these pregnancies occurred

Alebeek et al. \[[@CR28]\] assessed the occurrence of pregnancy complications in women with a history of stroke (IS or TIA) using the Dutch general population as a control group. The data for the women with a stroke history were self-reported and collected by telephone interview and the data to represent the general population was retrieved from the Dutch Perinatal Registry or Dutch HELLP foundation. The patients and controls were not matched on common risk factors for stroke and pregnancy complications (smoking, thrombophilia, hypertension, hypertensive disorders of pregnancy). In the subgroup of 20 women with PAS, 50% had experienced more than one miscarriage, 5% more than one foetal death, 25% gestational hypertension, 20% pre-eclampsia, 20% HELLP and 10% gestational diabetes. Substantially lower rates for the Dutch general population were reported: 13.5, 0.9, 11.7, 0.5, 0.5 and 1.8%, respectively. The study did not report the timing of the pregnancy outcomes in relation to the PAS, i.e. whether the complications occurred during the same pregnancy or not.

PAS recurrence {#Sec5}
--------------

In the 55 pregnancies among women with a history of PAS, one (2%) recurrent PAS occurred. This was a first trimester CVT in a woman with a history of CVT during pregnancy, sickle cell disease as an underlying condition. She used no prophylactic anticoagulant medication during the pregnancies following the primary CVT. The pregnancy was terminated. The study of Ciron et al. \[[@CR27]\] did not provide details on the primary or the recurrent CVT (i.e. the location or extend of CVT or did CVT result in ischemic or haemorrhagic stroke). In addition, four articles reporting subsequent health of women after PAS \[[@CR19], [@CR22], [@CR28], [@CR30]\] stated there were no recurrent PAS.

Subsequent health {#Sec6}
-----------------

Table [3](#Tab3){ref-type="table"} presents information on the subsequent health of women with PAS. The articles varied greatly in terms of the diseases, outcomes included in follow-up and outcomes reported for women with PAS. Often all outcomes of interest were not specifically reported for women with PAS. The follow-up time varied from 6 months to 16 years after the index stroke. The initial type of stroke was not specified in 90/123 women (73%) whose subsequent health was assessed and reported. During the follow-up there were altogether three vascular events, all ISs or TIAs from the study of Alebeek et al. \[[@CR28]\]. The studies reporting long-term mortality included 101 women and 10 (10%) of these women died during the follow-up time up to 16 years, four from cardiovascular causes and six from other causes. All of these women were from the same cohort from Gastrich et al. \[[@CR26]\] and had pre-eclampsia in association with the index stroke.Table 3Future health of women with PASAuthorWomen in cohort (n)PAS women *n* (%)Types of events included in follow-upCardiovascular events reported for PASMortalityUnderlying conditionDuration of follow-upAlebeek et al. (2018) \[[@CR28]\]21320 (9)Stroke or other arterial event, eg. MI or cardiovascular procedure3 recurrent ischaemic strokesnr2 SLE, 2 APS, 7 hypertension, 1 DM, 6 smokingmean 14.8, SD 10.0 yAppenzeller et al. (2005) \[[@CR24]\]186 (33)CVT or other thrombotic eventnonenonenonemean 46, range 11--145 moBreteau et al. (2003) \[[@CR21]\]423 (7)CVT recurrence, DVT, PE, any other health problem leading to hospitalisationno recurrent CVTnonenrmedian 36, range 12--60 moErtresvg et al. (2007)412 (5)Any new diseasesnonenone1 APS + pre-eclampsia, 1 smoking + family histrory of stroke + FV Leiden heterozygous5 yGastrich et al. (2012) \[[@CR26]\]35390 (25)MI, stroke, cardiovascular death, death from any causeno recurrent stroke, no MI4 cardiovascular deaths, 6 other deathspre-eclampsiaup to 16 yearsLanzino et al. (1991) \[[@CR19]\]592 (3)Cerebral ischemia, MI, deathno recurrent strokesnrnrmean 5.8 y, range 6 mo-11 y*CVT* cerebral venous thrombosis, *MI* myocardial infarction, *PE* pulmonary embolism, *DVT* deep venous thrombosis, *SLE* systemic lupus erythematosus, *APS* antiphospholipid syndrome, *DM* diabetes mellitus, *y* year, *mo* month, *nr* not reported for women with PAS

Discussion {#Sec7}
==========

During the past two decades knowledge on the incidence and risk factors of PAS has accumulated. By contrast, data on subsequent pregnancies and health of women with PAS are scattered, incompletely reported and limited information is available. The systematic review suggests that the incidence of pregnancy complications is comparable to that reported for women with a history of stroke (related or not related to pregnancy) \[[@CR20], [@CR21], [@CR27], [@CR31]\]. Miscarriage seems to be as common among women with PAS as in the general population \[[@CR32]\], but induced abortion is slightly more infrequent than in the general population \[[@CR33]\]. This may reflect more careful family planning after PAS. One study reported less favourable obstetric prognosis, more severe pregnancy complications and more miscarriages and foetal deaths in women with a history of stroke than in the general population \[[@CR28]\]. However, there are several methodological problems in the study. Most importantly, the ascertainment and data collection differed between the women with PAS and controls and they were not matched on risk factors for adverse pregnancy outcomes, such as smoking, hypertension and prothrombotic conditions, which all are also risk factors for stroke. Therefore, the findings may result from confounding risk factors. Also the frequencies of adverse pregnancy outcomes reported in the Dutch Perinatal Registry for the general populations are low and possibly under-reported \[[@CR28]\], which may overestimate the differences between women with a stroke history and general population.

Based on limited number of published cases, the proportion of women with subsequent pregnancies after PAS was relatively high, 50%. It is noteworthy that the percentage is based on less than half of the women with PAS included in the analysis of subsequent pregnancies, since two studies \[[@CR23], [@CR27]\] did not provide the data on number of women with subsequent pregnancies. This may overestimate the pregnancy rate. In previous studies, the proportion of young women with a history of stroke (related or not related to pregnancy) and subsequent pregnancies has ranged between 26 and 40% \[[@CR20], [@CR27], [@CR29], [@CR31], [@CR34]\]. Lamy et al. \[[@CR20]\] found no difference in the number of subsequent pregnancies between women with a history of IS or CVT and age- and parity-matched controls from the general population. However, one-third of women with a history of stroke indicated that they would have wished for more pregnancies after their stroke and the most common causes for hesitation were concerns of recurrent stroke, medical advice against a new pregnancy and residual disability \[[@CR20]\].

We found one recurrent PAS, CVT associated to sickle cell disease. Even though the number of patients is very limited, the recurrence of stroke during pregnancy or puerperium seems to be rare. The same applies to young stroke patients whose initial strokes have not been pregnancy related. The recurrence is mainly limited to women with underlying haematological diseases (such as protein C and S deficiency, sickle cell disease, antiphospholipid syndrome or systemic lupus erythematosus), cerebrovascular disease (arteriovenous malformations, aneurysms or Moyamoya disease) or maternal cardiac disease \[[@CR20], [@CR21], [@CR31], [@CR35], [@CR36]\]. This is exemplified by a study by Fischer-Betz et al. \[[@CR35]\] who reported pregnancy outcomes and recurrence of stroke during pregnancy for 20 women with antiphospholipid syndrome and a history of IS or TIA. The possible temporal connection of index stroke to pregnancy was not reported. Among subsequent pregnancies, stroke recurred in 15%, while preeclampsia occurred in 34% of pregnancies and 8.7% of pregnancies resulted in neonatal death. Further, Soriano et al. \[[@CR36]\] reported similar results in a study of thromboembolic complications of pregnancy and pregnancy outcomes in 12 women (15 pregnancies) with a history of stroke (IS, TIA and amaurosis fugax) and an underlying thrombophilic disorder who used LMWH and aspirin 100 mg until 6 weeks' postpartum. Five of these 12 women (42%) in the cohort had a history of PAS. Four patients (33%) in this cohort had recurrent thromboembolic events (1 TIA, 1 amaurosis fugax in two subsequent pregnancies, 1 paresthesia of the left arm, 1 deep venous thrombosis and pulmonary embolism 3 weeks postpartum after discontinuing the preventive medication contrary to advice). Pre-eclampsia complicated five pregnancies (33% of all), leading to preterm delivery in three pregnancies (20%), of which one at 27 gestational weeks, resulting in neonatal death (7% of newborns). Even though the proportion of PAS in this cohort was only 42%, this may indicate that also PAS women with an underlying predisposing condition are at greater risk of recurrent PAS, other thrombotic events and adverse pregnancy outcomes than women whose index PAS has been cryptogenic.

The studies reporting subsequent health of women after PAS differed markedly in terms of settings and outcomes included in the follow-up. In 73% of the women whose future health was reported, the stroke subtype was not specified. During the follow-up ranging from 6 months to 16 years, altogether three ISs occurred among 123 women, i.e. 2% of the women suffered a NPAS. All of these women were from the same cohort of 20 women with PAS, the cumulative 20-year risk being 15.6% when assessing this cohort separately. Hindfelt et al. \[[@CR37]\] found 11% of young IS survivors suffered a recurrence during the 13- to 26-year follow-up. The difference in their results compared with ours may be explained by a shorter follow-up time in the studies of our review, but also by a lower prevalence of traditional stroke risk factors among PAS women. Regarding mortality, we found a cumulative mortality rate of 10% after a follow-up ranging from 6 months to 16 years. This is in line with previous studies on the long-term prognosis of young patients with IS that have reported a cumulative 2- to 10-year mortality of 10% \[[@CR38], [@CR39]\].

This study has a number of limitations. All studies included in this review were comprised of mainly women with a history of stroke that was not associated with pregnancy, the proportion of PAS varying from 3 to 33%. Analyses were performed and results presented for the entire cohort instead of separating patients by the timing of the stroke, making it impossible to extract all outcomes included in the study for women with PAS specifically. The information about women with PAS, their subsequent pregnancies and their outcomes often had to be retrieved from tables in the articles or even from the discussion. A good example is the total number of pregnancies reported in the studies; two studies \[[@CR20], [@CR24]\] did not report miscarriages or induced abortions separately for women with PAS and Ciron et al. \[[@CR27]\] reported outcomes of pregnancies for only one woman with PAS, but did not state whether other women with PAS had pregnancies and what their possible outcomes were. Therefore, the total number of pregnancies for women with PAS in the included studies may be more than 55. Lamy at al. \[[@CR20]\] did not report pregnancy complications, which may underestimate their incidence. The quality of information varied and was especially scant regarding future cardiovascular health. The length of the follow-up period was insufficient for evaluation of long-term cardiovascular outcome and mortality. These gaps in reporting reflect that women with PAS were not the main focus in these articles. Altogether, the limited number of cases and incomplete reporting causes uncertainty for the interpretation of result. However, the results revealed an evident gap in knowledge that warrants research on this topic, preferably in a population-based setting and with a sufficiently long follow-up.

Conclusion {#Sec8}
==========

PAS is a rare event with potentially devastating consequences for the everyday life of the young family. In the systematic review of subsequent pregnancies and health of these women, we found the data to be limited. In the context of published literature, half of women with a history of PAS have subsequent pregnancies, their outcomes are generally good and the stroke recurrence rate during subsequent pregnancies is low. This is reassuring when it comes to counselling women with a desire to conceive. An increased risk of adverse events and recurrence of PAS may be related to subsequent pregnancies of women with underlying diseases such as prothrombotic conditions, anomalies of cerebral vasculature and chronic heart disease. According to the results of this review, the prognosis of future health is similar for women with a history of PAS and patients with a history of stroke at young age, unrelated to pregnancy. However, further research on this topic is needed to improve pregnancy surveillance, preventive medication in subsequent pregnancies and secondary prevention throughout life.
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CVT

:   Cerebral venous thrombosis

HELLP

:   Haemolysis, elevated liver enzyme, low platelet count

ICH

:   Intracerebral haemorrhage

IS

:   Ischaemic stroke

LMWH

:   Low molecular weight heparin

PAS

:   Pregnancy-associated stroke

SAH

:   Subarachnoid haemorrhage

SLE

:   Systemic lupus erythematosus

TIA

:   Transient ischaemic attack
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